Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Hiscock
Health Care Costs in Psoriasis Patients Newly Initiated on a Biologic Therapy or Methotrexate
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Treatment Persistence in Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pss23 - Switch Patterns and Total Costs in Biologic-Naive Patients Initiating Apremilast or a Biologic for the Treatment of Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
New Onset or Worsening of Psoriasis Following Biologic Therapy: A Case Series
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Study on the Efficacy and Adverse Effects of Methotrexate in Psoriasis Patients in a Tertiary Care Centre
International Journal of Basic & Clinical Pharmacology
Severity Index for Rheumatoid Arthritis and Its Association With Health Care Costs and Biologic Therapy Use in Turkey
Health Economics Review
Health Policy
Risk of Cancer in Patients With Psoriasis on Biologic Therapies: A Systematic Review
British Journal of Dermatology
Dermatology
Medicine
Methotrexate Hepatotoxicity in Psoriasis.
BMJ